Abstract
Marine organisms are known to be a rich and unique source of bioactive compounds as they are exposed to extreme conditions in the oceans. The present study is an attempt to briefly describe some of the important membrane-active peptides (MAPs) such as antimicrobial peptides (AMPs), cell-penetrating peptides (CPPs) and peptide toxins from marine organisms. Since both AMPs and CPPs play a role in membrane perturbation and exhibit interchangeable role, they can speculatively fall under the broad umbrella of MAPs. The study focuses on the structural and functional characteristics of different classes of marine MAPs. Further, AMPs are considered as a potential remedy to antibiotic resistance acquired by several pathogens. Peptides from marine organisms show novel post-translational modifications such as cysteine knots, halogenation and histidino–alanine bridge that enable these peptides to withstand harsh marine environmental conditions. These unusual modifications of AMPs from marine organisms are expected to increase their half-life in living systems, contributing to their increased bioavailability and stability when administered as drug in in vivo systems. Apart from AMPs, marine toxins with membrane-perturbing properties could be essentially investigated for their cytotoxic effect on various pathogens and their cell-penetrating activity across various mammalian cells. The current review will help in identifying the MAPs from marine organisms with crucial post-translational modifications that can be used as template for designing novel therapeutic agents and drug-delivery vehicles for treatment of human diseases.
Similar content being viewed by others
References
Jha RK, Zi-rong X (2004) Biomedical compounds from marine organisms. Mar Drugs 2:123–146. doi:10.3390/md203123
Aneiros A, Garateix A (2004) Bioactive peptides from marine sources: pharmacological properties and isolation procedures. J Chromatogr, B: Anal Technol Biomed Life Sci 803:41–53. doi:10.1016/j.jchromb.2003.11.005
Donia M, Hamann MT (2003) Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis 3:338–348
Simmons TL, Andrianasolo E, McPhail K et al (2005) Marine natural products as anticancer drugs. Mol Cancer Ther 4:333–342
Galdiero S, Falanga A, Cantisani M et al (2013) Peptide-lipid interactions: experiments and applications. Int J Mol Sci 14:18758–18789. doi:10.3390/ijms140918758
Wang Q, Hong G, Johnson GR et al (2010) Biophysical properties of membrane-active peptides based on micelle modeling: a case study of cell-penetrating and antimicrobial peptides. J Phys Chem B 114:13726–13735. doi:10.1021/jp1069362
Wadhwani P, Reichert J, Bürck J, Ulrich AS (2012) Antimicrobial and cell-penetrating peptides induce lipid vesicle fusion by folding and aggregation. Eur Biophys J 41:177–187. doi:10.1007/s00249-011-0771-7
Tincu JA, Taylor SW (2004) Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother 48:3645–3654. doi:10.1128/AAC.48.10.3645-3654.2004
Heitz F, Morris MC, Divita G (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157:195–206. doi:10.1111/j.1476-5381.2009.00057.x
Matsuzaki K, Yoneyama S, Murase O, Miyajima K (1996) Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry 35:8450–8456. doi:10.1021/bi960342a
Kerkis A, Kerkis I, Rádis-Baptista G et al (2004) Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus. FASEB J 18:1407–1409. doi:10.1096/fj.03-1459fje
Estève E, Mabrouk K, Dupuis A et al (2005) Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane. J Biol Chem 280:12833–12839. doi:10.1074/jbc.M412521200
Gurrola GB, Capes EM, Zamudio FZ et al (2010) Imperatoxin A, a cell-penetrating peptide from scorpion venom, as a probe of Ca-release channels/ryanodine receptors. Pharmaceuticals (Basel) 3:1093–1107. doi:10.3390/ph3041093
Hancock RE, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317–1323
Drider D, Rebuffat S (2011) Prokaryotic antimicrobial peptides: from genes to applications. doi:10.1007/978-1-4419-7692-5
Goldman MJ, Anderson GM, Stolzenberg ED et al (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553–560
Hancock RE, Scott MG (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97:8856–8861
Vizioli J, Salzet M (2002) Antimicrobial peptides versus parasitic infections? Trends Parasitol 18:475–476
Baltzer SA, Brown MH (2011) Antimicrobial peptides: promising alternatives to conventional antibiotics. J Mol Microbiol Biotechnol 20:228–235. doi:10.1159/000331009
Allsopp M, Pambuccian SE, Johnston P, Santillo D (2009) State of the world’s oceans
Wang G, Li X, Wang Z (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37:D933–D937. doi:10.1093/nar/gkn823
Ammerman JW, Fuhrman JA, Hagstrom A, Azam F (1984) Bacterioplankton growth in seawater: I. Growth kinetics and cellular characteristics in seawater cultures. Mar Ecol Prog Ser 18:31–39
Patrzykat A, Douglas SE (2003) Gone gene fishing: how to catch novel marine antimicrobials. Trends Biotechnol 21:362–369. doi:10.1016/S0167-7799(03)00145-8
Otero-González AJ, Magalhães BS, Garcia-Villarino M et al (2010) Antimicrobial peptides from marine invertebrates as a new frontier for microbial infection control. FASEB J 24:1320–1334. doi:10.1096/fj.09-143388
Smith VJ, Desbois AP, Dyrynda EA (2010) Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar Drugs 8:1213–1262. doi:10.3390/md8041213
Sperstad SV, Haug T, Blencke H-M et al (2011) Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery. Biotechnol Adv 29:519–530. doi:10.1016/j.biotechadv.2011.05.021
Wang G (2012) Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering. Curr Biotechnol 1:72–79
Shinnar AE, Butler KL, Park HJ (2003) Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance. Bioorg Chem 31:425–436. doi:10.1016/S0045-2068(03)00080-4
Li C, Haug T, Styrvold OB et al (2008) Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis. Dev Comp Immunol 32:1430–1440. doi:10.1016/j.dci.2008.06.013
Lee IH, Cho Y, Lehrer RI (1997) Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava. Comp Biochem Physiol B: Biochem Mol Biol 118:515–521
Taylor SW, Craig AG, Fischer WH et al (2000) Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. J Biol Chem 275:38417–38426. doi:10.1074/jbc.M006762200
Zabriskie TM, Klocke JA, Ireland CM et al (1986) Jaspamide, a modified peptide from a Jaspis sponge, with insecticidal and antifungal activity. J Am Chem Soc 108:3123–3124. doi:10.1021/ja00271a062
Fedders H, Michalek M, Grötzinger J, Leippe M (2008) An exceptional salt-tolerant antimicrobial peptide derived from a novel gene family of haemocytes of the marine invertebrate Ciona intestinalis. Biochem J 416:65–75. doi:10.1042/BJ20080398
Andrès E, Dimarcq JL (2004) Cationic antimicrobial peptides: update of clinical development. J Intern Med 255:519–520. doi:10.1046/j.1365-2796.2003.01278.x
Ge Y, MacDonald DL, Holroyd KJ et al (1999) In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 43:782–788
Lamb HM, Wiseman LR (1998) Pexiganan acetate. Drugs 56:1047–1052 (discussion 1053–4)
Trotti A, Garden A, Warde P et al (2004) A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys 58:674–681. doi:10.1016/S0360-3016(03)01627-4
Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468–472. doi:10.1016/j.coph.2006.04.006
Domingues MM, Santos NC, Castanho MARB (2012) Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies. Curr Protein Pept Sci 13:611–619
Naghmouchi K, Baah J, Hober D et al (2013) Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother 57:2719–2725. doi:10.1128/AAC.02328-12
Naghmouchi K, Drider D, Baah J, Teather R (2010) Nisin A and polymyxin B as synergistic inhibitors of Gram-positive and Gram-negative bacteria. Probiot Antimicrob Proteins 2:98–103. doi:10.1007/s12602-009-9033-8
Moulton HM (2013) In vivo delivery of morpholino oligos by cell-penetrating peptides. Curr Pharm Des 19:2963–2969
Erazo-Oliveras A, Najjar K, Dayani L et al (2014) Protein delivery into live cells by incubation with an endosomolytic agent. Nat Methods 11:861–867. doi:10.1038/nmeth.2998
Chen Z, Zhang P, Cheetham AG et al (2014) Controlled release of free doxorubicin from peptide-drug conjugates by drug loading. J Control Release 191:123–130. doi:10.1016/j.jconrel.2014.05.051
Hearst SM, Shao Q, Lopez M et al (2014) The design and delivery of a PKA inhibitory polypeptide to treat SCA1. J Neurochem. doi:10.1111/jnc.12782
Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189–1193
Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 88:1864–1868
Elmquist A, Lindgren M, Bartfai T, Langel U (2001) VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269:237–244. doi:10.1006/excr.2001.5316
Tunnemann G, Ter-Avetisyan G, Martin RM et al (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J Pept Sci 14:469–476. doi:10.1002/psc
Oehlke J, Scheller A, Wiesner B et al (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta 1414:127–139
Walrant A, Matheron L, Cribier S et al (2013) Direct translocation of cell-penetrating peptides in liposomes: a combined mass spectrometry quantification and fluorescence detection study. Anal Biochem 438:1–10. doi:10.1016/j.ab.2013.03.009
Eguchi A, Akuta T, Okuyama H et al (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276:26204–26210. doi:10.1074/jbc.M010625200
Chugh A, Amundsen E, Eudes F (2009) Translocation of cell-penetrating peptides and delivery of their cargoes in triticale microspores. Plant Cell Rep 28:801–810. doi:10.1007/s00299-009-0692-4
Splith K, Neundorf I (2011) Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40:387–397. doi:10.1007/s00249-011-0682-7
Nekhotiaeva N, Elmquist A, Rajarao GK et al (2004) Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J 18:394–396. doi:10.1096/fj.03-0449fje
Palm C, Netzereab S, Hällbrink M (2006) Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27:1710–1716. doi:10.1016/j.peptides.2006.01.006
Zhu WL, Shin SY (2009) Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action. J Pept Sci 15:345–352. doi:10.1002/psc.1120
Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253–257. doi:10.1006/bbrc.1998.8159
Takeshima K, Chikushi A, Lee K-K et al (2003) Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem 278:1310–1315. doi:10.1074/jbc.M208762200
Pushpanathan M, Gunasekaran P, Rajendhran J (2013) Mechanisms of the antifungal action of marine metagenome-derived peptide, MMGP1, against Candida albicans. PLoS ONE 8:e69316. doi:10.1371/journal.pone.0069316
Fusetani N, Kem W (2009) Marine toxins: an overview. Prog Mol Subcell Biol 46:1–44. doi:10.1007/978-3-540-87895-7_1
Parker MW, Feil SC (2005) Pore-forming protein toxins: from structure to function. Prog Biophys Mol Biol 88:91–142. doi:10.1016/j.pbiomolbio.2004.01.009
Oren Z, Shai Y (1996) A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur J Biochem 237:303–310
Fedorov S, Dyshlovoy S, Monastyrnaya M et al (2010) The anticancer effects of actinoporin RTX-A from the sea anemone Heteractis crispa (= Radianthus macrodactylus). Toxicon 55:811–817. doi:10.1016/j.toxicon.2009.11.016
Tejuca M, Anderluh G, Macek P et al (1999) Antiparasite activity of sea-anemone cytolysins on Giardia duodenalis and specific targeting with anti-Giardia antibodies. Int J Parasitol 29:489–498
Anderluh G, Macek P (2002) Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria). Toxicon 40:111–124
Anderluh G, Pungercar J, Strukelj B et al (1996) Cloning, sequencing, and expression of equinatoxin II. Biochem Biophys Res Commun 220:437–442. doi:10.1006/bbrc.1996.0391
Anderluh G, Barlic A, Podlesek Z et al (1999) Cysteine-scanning mutagenesis of an eukaryotic pore-forming toxin from sea anemone: topology in lipid membranes. Eur J Biochem 263:128–136
Lanio ME, Morera V, Alvarez C et al (2001) Purification and characterization of two hemolysins from Stichodactyla helianthus. Toxicon 39:187–194
Wang Y, Chua KL, Khoo HE (2000) A new cytolysin from the sea anemone, Heteractis magnifica: isolation, cDNA cloning and functional expression. Biochim Biophys Acta 1478:9–18
Terwilliger TC, Eisenberg D (1982) The structure of melittin. II. Interpretation of the structure. J Biol Chem 257:6016–6022
Steiner H (1982) Secondary structure of the cecropins: antibacterial peptides from the moth Hyalophora cecropia. FEBS Lett 137:283–287
Hinds MG, Zhang W, Anderluh G et al (2002) Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II: implications for pore formation. J Mol Biol 315:1219–1229. doi:10.1006/jmbi.2001.5321
Jackson KE, Spielmann T, Hanssen E et al (2007) Selective permeabilization of the host cell membrane of Plasmodium falciparum-infected red blood cells with streptolysin O and equinatoxin II. Biochem J 403:167–175. doi:10.1042/BJ20061725
Zhang M, Fishman Y, Sher D, Zlotkin E (2003) Hydralysin, a novel animal group-selective paralytic and cytolytic protein from a noncnidocystic origin in hydra. Biochemistry 42:8939–8944. doi:10.1021/bi0343929
Sher D, Zlotkin E (2009) A hydra with many heads: protein and polypeptide toxins from hydra and their biological roles. Toxicon 54:1148–1161. doi:10.1016/j.toxicon.2009.02.036
Sher D, Fishman Y, Zhang M et al (2005) Hydralysins, a new category of beta-pore-forming toxins in cnidaria. J Biol Chem 280:22847–22855. doi:10.1074/jbc.M503242200
Lazarovici P, Primor N, Loew LM (1986) Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus). J Biol Chem 261:16704–16713
Shai Y, Bach D, Yanovsky A (1990) Channel formation properties of synthetic pardaxin and analogues. J Biol Chem 265:20202–20209
Hallock KJ, Lee D-K, Omnaas J et al (2002) Membrane composition determines pardaxin’s mechanism of lipid bilayer disruption. Biophys J 83:1004–1013. doi:10.1016/S0006-3495(02)75226-0
Dhople V, Krukemeyer A, Ramamoorthy A (2006) The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta 1758:1499–1512. doi:10.1016/j.bbamem.2006.07.007
Blumenthal KM (1982) Structure and action of heteronemertine polypeptide toxins. Membrane penetration by Cerebratulus lacteus toxin A-III. Biochemistry 21:4229–4233
Kem WR (1994) Structure and membrane actions of a marine worm protein cytolysin, Cerebratulus toxin A-III. Toxicology 87:189–203
Lehrer RI, Lee IH, Menzel L et al (2001) Clavanins and styelins, alpha-helical antimicrobial peptides from the hemocytes of Styela clava. Adv Exp Med Biol 484:71–76
Pundir P, Catalli A, Leggiadro C et al (2014) Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor. Mucosal Immunol 7:177–187. doi:10.1038/mi.2013.37
Lee S-A, Kim YK, Lim SS et al (2007) Solution structure and cell selectivity of piscidin 1 and its analogues. Biochemistry 46:3653–3663. doi:10.1021/bi062233u
Pushpanathan M, Rajendhran J, Jayashree S et al (2012) Identification of a novel antifungal peptide with chitin-binding property from marine metagenome. Protein Pept Lett 19:1289–1296
Kolusheva S, Lecht S, Derazon Y et al (2008) Pardaxin, a fish toxin peptide interaction with a biomimetic phospholipid/polydiacetylene membrane assay. Peptides 29:1620–1625. doi:10.1016/j.peptides.2008.05.012
Bringezu F, Wen S, Dante S et al (2007) The insertion of the antimicrobial peptide dicynthaurin monomer in model membranes: thermodynamics and structural characterization. Biochemistry 46:5678–5686. doi:10.1021/bi7001295
Jang WS, Kim KN, Lee YS et al (2002) Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett 521:81–86
Cespedes GF, Lorenzón EN, Vicente EF et al (2012) Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus. Protein Pept Lett 19:596–603
Stensvåg K, Haug T, Sperstad SV et al (2008) Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Dev Comp Immunol 32:275–285. doi:10.1016/j.dci.2007.06.002
Sperstad SV, Haug T, Vasskog T, Stensvåg K (2009) Hyastatin, a glycine-rich multi-domain antimicrobial peptide isolated from the spider crab (Hyas araneus) hemocytes. Mol Immunol 46:2604–2612. doi:10.1016/j.molimm.2009.05.002
Yang Y, Poncet J, Garnier J et al (2003) Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide. J Biol Chem 278:36859–36867. doi:10.1074/jbc.M305450200
Roch P, Yang Y, Toubiana M, Aumelas A (2008) NMR structure of mussel mytilin, and antiviral-antibacterial activities of derived synthetic peptides. Dev Comp Immunol 32:227–238. doi:10.1016/j.dci.2007.05.006
Bakrac B, Gutiérrez-Aguirre I, Podlesek Z et al (2008) Molecular determinants of sphingomyelin specificity of a eukaryotic pore-forming toxin. J Biol Chem 283:18665–18677. doi:10.1074/jbc.M708747200
Mancheño JM, Martín-Benito J, Martínez-Ripoll M et al (2003) Crystal and electron microscopy structures of sticholysin II actinoporin reveal insights into the mechanism of membrane pore formation. Structure 11:1319–1328. doi:10.1016/j.str.2003.09.019
Athanasiadis A, Anderluh G, Maček P, Turk D (2001) Crystal structure of the soluble form of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina. Structure 9:341–346. doi:10.1016/S0969-2126(01)00592-5
Hong Q, Gutierrez-Aguirre I, Barlic A et al (2002) Two-step membrane binding by equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix. Biochemistry 277:41916–41924. doi:10.1074/jbc.M204625200
Alegre-Cebollada J, Cunietti M, Herrero-Galán E et al (2008) Calorimetric scrutiny of lipid binding by sticholysin II toxin mutants. J Mol Biol 382:920–930. doi:10.1016/j.jmb.2008.07.053
Malovrh P, Viero G, Serra MD et al (2003) A novel mechanism of pore formation: membrane penetration by the N-terminal amphipathic region of equinatoxin. J Biol Chem 278:22678–22685. doi:10.1074/jbc.M300622200
Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236–248. doi:10.1002/bip.10260
La Rocca P, Biggin PC, Tieleman DP, Sansom MS (1999) Simulation studies of the interaction of antimicrobial peptides and lipid bilayers. Biochim Biophys Acta 1462:185–200
Gazit E, Lee WJ, Brey PT, Shai Y (1994) Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. Biochemistry 33:10681–10692
Stark M, Liu L-P, Deber CM (2002) Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother 46:3585–3590
Shai Y, Oren Z (2001) From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22:1629–1641
Gidalevitz D, Ishitsuka Y, Muresan AS et al (2003) Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci USA 100:6302–6307. doi:10.1073/pnas.0934731100
Yang L, Harroun TA, Weiss TM et al (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81:1475–1485. doi:10.1016/S0006-3495(01)75802-X
Spaar A, Münster C, Salditt T (2004) Conformation of peptides in lipid membranes studied by X-ray grazing incidence scattering. Biophys J 87:396–407. doi:10.1529/biophysj.104.040667
Murzyn K, Pasenkiewicz-Gierula M (2003) Construction of a toroidal model for the magainin pore. J Mol Model 9:217–224. doi:10.1007/s00894-003-0127-z
Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758:1292–1302. doi:10.1016/j.bbamem.2006.02.001
Anderluh G, Dalla Serra M, Viero G et al (2003) Pore formation by equinatoxin II, a eukaryotic protein toxin, occurs by induction of nonlamellar lipid structures. J Biol Chem 278:45216–45223. doi:10.1074/jbc.M305916200
Alvarez C, Mancheño JM, Martínez D et al (2009) Sticholysins, two pore-forming toxins produced by the Caribbean Sea anemone Stichodactyla helianthus: their interaction with membranes. Toxicon 54:1135–1147. doi:10.1016/j.toxicon.2009.02.022
Park CB, Lee JH, Park IY et al (1997) A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus. FEBS Lett 411:173–178
Jung HJ, Park Y, Sung WS et al (2007) Fungicidal effect of pleurocidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance. Biochim Biophys Acta 1768:1400–1405. doi:10.1016/j.bbamem.2007.02.024
Lauth X, Shike H, Burns JC et al (2002) Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem 277:5030–5039. doi:10.1074/jbc.M109173200
Broekman DC, Zenz A, Gudmundsdottir BK et al (2011) Functional characterization of codCath, the mature cathelicidin antimicrobial peptide from Atlantic cod (Gadus morhua). Peptides 32:2044–2051. doi:10.1016/j.peptides.2011.09.012
Pan C-Y, Chen J-Y, Cheng Y-SE et al (2007) Gene expression and localization of the epinecidin-1 antimicrobial peptide in the grouper (Epinephelus coioides), and its role in protecting fish against pathogenic infection. DNA Cell Biol 26:403–413. doi:10.1089/dna.2006.0564
Shiomi K, Igarashi T, Yokota H et al (2000) Isolation and structures of grammistins, peptide toxins from the skin secretion of the soapfish Grammistes sexlineatus. Toxicon 38:91–103
Campagna S, Saint N, Molle G, Aumelas A (2007) Structure and mechanism of action of the antimicrobial peptide piscidin. Biochemistry 46:1771–1778. doi:10.1021/bi0620297
Sato K, Horibe K, Amano K et al (2006) Membrane permeabilization induced by discodermin A, a novel marine bioactive peptide. Toxicon 39:259–264
Matsunaga S, Fusetani N, Hashimoto K, Walchli M (1989) Theonellamide F. A novel antifungal bicyclic peptide from a marine sponge Theonella sp. J Am Chem Soc 111:2582–2588. doi:10.1021/ja00189a035
Li HY, Matsunaga S, Fusetani N (1995) Halicylindramides A-C, antifungal and cytotoxic depsipeptides from the marine sponge Halichondria cylindrata. J Med Chem 38:338–343
Ovchinnikova TV, Balandin SV, Aleshina GM et al (2006) Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins. Biochem Biophys Res Commun 348:514–523. doi:10.1016/j.bbrc.2006.07.078
Pan W, Liu X, Ge F et al (2004) Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization. J Biochem 135:297–304
Tasiemski A, Schikorski D, Le Marrec-Croq F et al (2007) Hedistin: a novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor. Dev Comp Immunol 31:749–762. doi:10.1016/j.dci.2006.11.003
Lee J-U, Kang D-I, Zhu WL et al (2007) Solution structures and biological functions of the antimicrobial peptide, arenicin-1, and its linear derivative. Biopolymers 88:208–216. doi:10.1002/bip.20700
Tasiemski A, Vandenbulcke F, Mitta G et al (2004) Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum. J Biol Chem 279:30973–30982. doi:10.1074/jbc.M312156200
Destoumieux D, Munoz M, Bulet P, Bachère E (2000) Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda). Cell Mol Life Sci 57:1260–1271
Noga EJ, Stone KL, Wood A et al (2011) Primary structure and cellular localization of callinectin, an antimicrobial peptide from the blue crab. Dev Comp Immunol 35:409–415. doi:10.1016/j.dci.2010.11.015
Lee SY, Lee BL, Söderhäll K (2003) Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus. J Biol Chem 278:7927–7933. doi:10.1074/jbc.M209239200
Nakamura T, Furunaka H, Miyata T et al (1988) Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J Biol Chem 263:16709–16713
Osaki T, Omotezako M, Nagayama R et al (1999) Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins. J Biol Chem 274:26172–26178
Charlet M, Chernysh S, Philippe H et al (1996) Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis. J Biol Chem 271:21808–21813
Mitta G, Hubert F, Noël T, Roch P (1999) Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis. Eur J Biochem 265:71–78
Mitta G, Vandenbulcke F, Hubert F, Roch P (1999) Mussel defensins are synthesised and processed in granulocytes then released into the plasma after bacterial challenge. J Cell Sci 112(Pt 2):4233–4242
Andrä J, Jakovkin I, Grötzinger J et al (2008) Structure and mode of action of the antimicrobial peptide arenicin. Biochem J 410:113–122. doi:10.1042/BJ20071051
Dennison SR, Phoenix AJ, Phoenix DA (2012) Effect of salt on the interaction of Hal18 with lipid membranes. Eur Biophys J 41:769–776. doi:10.1007/s00249-012-0840-6
Shin YP, Park HJ, Shin SH et al (2010) Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases. Antimicrob Agents Chemother 54:2855–2866. doi:10.1128/AAC.01790-09
Lin W, Liu S, Hu L, Zhang S (2014) Characterization and bioactivity of hepcidin-2 in zebrafish: dependence of antibacterial activity upon disulfide bridges. Peptides 57:36–42. doi:10.1016/j.peptides.2014.04.014
Andreu D, Rivas L (1998) Animal antimicrobial peptides: an overview. Biopolymers 47:415–433. doi:10.1002/(SICI)1097-0282(1998)47:6<415:AID-BIP2>3.0.CO;2-D
Lee IH, Cho Y, Lehrer RI (1997) Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 65:2898–2903
Van Kan EJM, Demel RA, Breukink E et al (2002) Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry 41:7529–7539
Lehrer RI, Andrew Tincu J, Taylor SW et al (2003) Natural Peptide antibiotics from tunicates: structures, functions and potential uses. Integr Comp Biol 43:313–322. doi:10.1093/icb/43.2.313
Gulavita NK, Gunasekera SP, Pomponi SA, Robinson EV (1992) Polydiscamide A: a new bioactive depsipeptide from the marine sponge Discodermia sp. J Org Chem 57:1767–1772. doi:10.1021/jo00032a031
Azumi K, Yokosawa H, Ishii S (1990) Halocyamines: novel antimicrobial tetrapeptide-like substances isolated from the hemocytes of the solitary ascidian Halocynthia roretzi. Biochemistry 29:159–165
Tincu JA, Menzel LP, Azimov R et al (2003) Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes. J Biol Chem 278:13546–13553. doi:10.1074/jbc.M211332200
Kato Y, Fusetani N, Matsunaga S et al (1988) Bioactive marine metabolites. 24. Isolation and structure elucidation of calyculins B, C, and D, novel antitumor metabolites, from the marine sponge Discodermia calyx. J Org Chem 53:3930–3932. doi:10.1021/jo00252a009
Capon RJ, Ford J, Lacey E et al (2002) Phoriospongin A and B: two new nematocidal depsipeptides from the Australian marine sponges Phoriospongia sp. and Callyspongia bilamellata. J Nat Prod 65:358–363
Monastyrnaya MM, Zykova TA, Apalikova OV et al (2002) Biologically active polypeptides from the tropical sea anemone Radianthus macrodactylus. Toxicon 40:1197–1217
Grotendorst GR, Hessinger DA (1999) Purification and partial characterization of the phospholipase A2 and co-lytic factor from sea anemone (Aiptasia pallida) nematocyst venom. Toxicon 37:1779–1796
Cline EI, Wiebe LI, Young JD, Samuel J (1995) Toxic effects of the novel protein UpI from the sea anemone Urticina piscivora. Pharmacol Res 32:309–314
Bernheimer AW, Lois SA (1978) A cholesterol-inhibitable cytolytic from the sea anemone Metridium senile. Biochim Biophys Acta 541:96–106. doi:10.1016/0304-4165(78)90270-2
Acknowledgments
NP, DPB and BKY are thankful to University Grants Commission, India, Indian Council of Medical Research, India, Council of Scientific and Industrial Research, India, respectively, for the award of Junior/Senior Research Fellowship.
Conflict of interest
The author’s declares that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Nisha Ponnappan and Deepthi Poornima Budagavi have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ponnappan, N., Budagavi, D.P., Yadav, B.K. et al. Membrane-Active Peptides from Marine Organisms—Antimicrobials, Cell-Penetrating Peptides and Peptide Toxins: Applications and Prospects. Probiotics & Antimicro. Prot. 7, 75–89 (2015). https://doi.org/10.1007/s12602-014-9182-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12602-014-9182-2